We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$2.67B
AUM Growth
-$17.4M
Cap. Flow
+$299M
Cap. Flow %
11.19%
Top 10 Hldgs %
14.24%
Holding
2,025
New
817
Increased
301
Reduced
302
Closed
527

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$110M
2
AMZN icon
Amazon
AMZN
+$95.8M
3
CRM icon
Salesforce
CRM
+$86.9M
4
META icon
Meta Platforms (Facebook)
META
+$46.4M
5
PHYS icon
Sprott Physical Gold
PHYS
+$42.3M

Sector Composition

Rank Sector Weight
1 Healthcare 9.09%
2 Financials 8.39%
3 Technology 8.23%
4 Consumer Discretionary 4.74%
5 Energy 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWO
1451
Two Harbors Investment
TWO
$1.27B
$99K ﹤0.01%
+3,380
New +$92.6K
COGT icon
1452
Cogent Biosciences
COGT
$7.32B
$98K ﹤0.01%
+11,109
New +$107K
BENER
1453
DELISTED
Benessere Capital Acquisition Corp. Right
BENER
$98K ﹤0.01%
+300,000
New +$113K
CFRX
1454
DELISTED
ContraFect Corporation
CFRX
$96K ﹤0.01%
+250
New +$108K
CYCN icon
1455
Cyclerion Therapeutics
CYCN
$15.2M
$95K ﹤0.01%
+1,706
New +$128K
BRQS
1456
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$93K ﹤0.01%
+326
New +$98K
BRLIR
1457
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$90K ﹤0.01%
299,155
BREZR
1458
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$81K ﹤0.01%
300,000
-456,836
-60% -$135K
EBON icon
1459
Ebang International Holdings
EBON
$11.7M
$80K ﹤0.01%
+333
New +$71.3K
CEMI
1460
DELISTED
Chembio diagnostics, Inc.
CEMI
$80K ﹤0.01%
22,832
CLOV icon
1461
Clover Health Investments
CLOV
$2.25B
$79K ﹤0.01%
+10,420
New +$118K
GRI
1462
GRI Bio
GRI
$2.82M
0
IRD
1463
Opus Genetics
IRD
$306M
$78K ﹤0.01%
+13,389
New +$124K
SYRS
1464
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$77K ﹤0.01%
1,030
APTO
1465
DELISTED
Aptose Biosciences, Inc.
APTO
$73K ﹤0.01%
+27
New +$53.5K
HPK icon
1466
HighPeak Energy
HPK
$864M
$68K ﹤0.01%
+11,198
New +$142K
ASMB icon
1467
Assembly Biosciences
ASMB
$524M
$56K ﹤0.01%
1,012
-693
-41% -$45.9K
ITRM
1468
DELISTED
Iterum Therapeutics
ITRM
$56K ﹤0.01%
+2,667
New +$63.5K
CCO icon
1469
Clear Channel Outdoor Holdings
CCO
$1.24B
$39K ﹤0.01%
+21,905
New +$41.5K
CRVS icon
1470
Corvus Pharmaceuticals
CRVS
$1.17B
$34K ﹤0.01%
+11,200
New +$40.5K
CREXW
1471
DELISTED
Creative Realities, Inc. Warrant
CREXW
$22K ﹤0.01%
12,236
BXRX
1472
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$18K ﹤0.01%
10
SLNO
1473
DELISTED
Soleno Therapeutics
SLNO
$16K ﹤0.01%
861
CFMS
1474
DELISTED
Conformis, Inc. Common Stock
CFMS
$15K ﹤0.01%
+600
New +$16.2K
TLGT
1475
DELISTED
Teligent, Inc
TLGT
$8K ﹤0.01%
13,369

Similar funds

Boothbay Fund Management's Q1 2021 Portfolio in Review

As of Q1 2021, Boothbay Fund Management held 2,025 positions worth $2.67B, down 0.65% from $2.69B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $299M of net new capital in Q1 2021, opening 817 new positions and adding to 301 existing holdings. Its largest new stake was Lumentum: 2,530,000 shares worth $4.06M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $110M trimmed.

  • Boothbay Fund Management's largest Q1 2021 buy was Lumentum: 2,530,000 shares worth $4.06M.
  • Boothbay Fund Management added most to Shopify in Q1 2021, an estimated $561M increase.
  • Boothbay Fund Management's biggest Q1 2021 reduction was Alibaba, cutting an estimated $110M.
  • Boothbay Fund Management fully exited Sprott Physical Gold in Q1 2021, selling an estimated $42.3M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $2.67B portfolio in Q1 2021.
  • Boothbay Fund Management opened 817 new positions and closed 527 in Q1 2021.
  • Boothbay Fund Management's portfolio value fell 0.65% quarter-over-quarter to $2.67B.

Based on Boothbay Fund Management's 13F filing for Q1 2021, filed 17 May 2021.